DXCM vs. GH: DexCom vs. Guardant Health Stock Comparison
How do DexCom (DXCM) and Guardant Health (GH) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
DexCom (DXCM) and Guardant Health (GH) both fall under the Health Care Equipment & Services industry group, but DXCM is classified in Health Care Equipment & Supplies while GH is classified in Health Care Providers & Services.
| Profile Item | DXCM | GH |
|---|---|---|
| Name | DexCom Inc. | Guardant Health, Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Equipment | Health Care Services |
| Market Capitalization | 29.62 billion USD | 20.41 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | Nasdaq |
| Listing Date | April 14, 2005 | October 4, 2018 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | DXCM | GH |
|---|---|---|
| Total Return (1Y) | 46.33% | 66.53% |
| Total Return (3Y, Annualized) | -4.50% | 92.76% |
| Total Return (5Y, Annualized) | -12.76% | 8.36% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | DXCM | GH |
|---|---|---|
| Volatility (1Y, Annualized) | 38.37% | 53.23% |
| Beta (5Y) | 1.43 | 1.69 |
| Max Drawdown (5Y) | -66.32% | -85.09% |
| Avg. Volume (3M) | 4.34M | 1.97M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | DXCM | GH |
|---|---|---|
| Sharpe Ratio (1Y) | 1.10 | 1.17 |
| Sortino Ratio (1Y) | 1.79 | 1.84 |
Profitability
ROE (TTM)
Capital efficiency shows on one side only: DexCom (DXCM) earns 37.67% on shareholders’ equity, ranked against its industry; Guardant Health (GH) has no ROE this period.
DXCM
Health Care Equipment & Services industry group
37.67%
- Max
- 47.61%
- DXCM
- 37.67%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
GH
Health Care Equipment & Services industry group
--
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
- GH
- --
Net Margin (TTM)
Guardant Health (GH) reports a negative net margin of -37.93%, usually indicating a net loss over the period. Meanwhile DexCom (DXCM) reports 19.42%, ranking against industry peers normally.
DXCM
Health Care Equipment & Services industry group
19.42%
- Max
- 29.35%
- DXCM
- 19.42%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
GH
Health Care Equipment & Services industry group
-37.93%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
- GH
- -37.93%
Operating Margin (TTM)
Guardant Health (GH) reports a negative operating margin of -37.06%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile DexCom (DXCM) reports 24.34%, ranking against industry peers normally.
DXCM
Health Care Equipment & Services industry group
24.34%
- Max
- 35.43%
- DXCM
- 24.34%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
GH
Health Care Equipment & Services industry group
-37.06%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
- GH
- -37.06%
Profitability Metrics
| Metric | DXCM | GH |
|---|---|---|
| ROE (TTM) | 37.67% | -- |
| ROA (TTM) | 11.14% | -19.92% |
| Net Margin (TTM) | 19.42% | -37.93% |
| Operating Margin (TTM) | 24.34% | -37.06% |
| Gross Margin (TTM) | 63.42% | 65.19% |
Growth
Revenue Growth
Guardant Health (GH) at 32.88% sits in the top revenue growth quartile, while DexCom (DXCM) at 15.60% is closer to the peer norm — faster top-line expansion for GH.
EPS Growth
Only one side can be read here: DexCom (DXCM) reports EPS growth of 47.18%, ranked against its industry; Guardant Health (GH) has no EPS growth figure this period.
Growth Metrics
| Metric | DXCM | GH |
|---|---|---|
| Revenue Growth (YoY) | 15.60% | 32.88% |
| Revenue Growth (3Y CAGR) | 17.01% | 29.75% |
| EPS Growth (YoY) | 47.18% | -- |
| EPS Growth (3Y CAGR) | 36.60% | -- |
Financial Strength
Current Ratio (MRQ)
Both DexCom (DXCM) at 1.74 and Guardant Health (GH) at 3.60 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
DXCM
Health Care Equipment & Services industry group
1.74
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DXCM
- 1.74
- Q1
- 1.37
- Min
- 0.30
GH
Health Care Equipment & Services industry group
3.60
- Max
- 7.59
- Q3
- 4.00
- GH
- 3.60
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Only one side’s leverage can be read here: DexCom (DXCM) carries debt-to-equity ratio of 0.55 against its industry range, while Guardant Health (GH) reports no figure this period.
DXCM
Health Care Equipment & Services industry group
0.55
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- DXCM
- 0.55
- Q1
- 0.16
- Min
- 0.00
GH
Health Care Equipment & Services industry group
--
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
- GH
- --
Financial Strength Metrics
| Metric | DXCM | GH |
|---|---|---|
| Current Ratio (MRQ) | 1.74 | 3.60 |
| Debt / Equity (MRQ) | 0.55 | -- |
| Net Debt / EBITDA | -0.28 | -- |
Dividends
Dividend Yield (TTM)
Neither DexCom (DXCM) nor Guardant Health (GH) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
GH
Health Care Equipment & Services industry group
0.00%
- GH
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither DexCom (DXCM) nor Guardant Health (GH) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
GH
Health Care Equipment & Services industry group
0.00%
- GH
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | DXCM | GH |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: DexCom (DXCM) trades at 31.26 times trailing earnings, ranked against its peers, while Guardant Health (GH) has no P/E ratio this period.
DXCM
Health Care Equipment & Services industry group
31.26
- Max
- 80.41
- Q3
- 47.62
- DXCM
- 31.26
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
GH
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- GH
- --
P/S Ratio (TTM)
Both look expensive on sales: DexCom (DXCM) at 5.80 sits in the upper P/S ratio quartile, and Guardant Health (GH) at 15.96 prices even higher, above its industry range.
DXCM
Health Care Equipment & Services industry group
5.80
- Max
- 8.80
- DXCM
- 5.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
GH
Health Care Equipment & Services industry group
15.96
- GH
- 15.96
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Guardant Health (GH) reports a negative P/B ratio of -73.67, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile DexCom (DXCM) reports 11.68, ranking against industry peers normally.
DXCM
Health Care Equipment & Services industry group
11.68
- DXCM
- 11.68
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
GH
Health Care Equipment & Services industry group
-73.67
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
- GH
- -73.67
Valuation Metrics
| Metric | DXCM | GH |
|---|---|---|
| P/E Ratio (TTM) | 31.26 | -- |
| P/S Ratio (TTM) | 5.80 | 15.96 |
| P/B Ratio (MRQ) | 11.68 | -73.67 |
| Free Cash Flow Yield (TTM) | 2.74% | -0.30% |